Adrienne L Graves insider trades
Open-market stock purchases and sales by Adrienne L Graves, Director at Harrow, Inc, from SEC Form 4 filings since Jan 1, 2010.
Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +7%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jun 18, 2026 | HROW Harrow, Inc | Bought (not open market) | — |
| Jun 10, 2026 | OCUL Ocular Therapeutix, Inc | Bought (not open market) | — |
| Jun 10, 2026 | OCUL Ocular Therapeutix, Inc | Bought (not open market) | — |
| May 18, 2026 | HROW Harrow, Inc | Bought | $31.1K |
| Apr 20, 2026 | IRD Opus Genetics, Inc | Bought (not open market) | — |
| Jan 1, 2026 | IRD Opus Genetics, Inc | Bought (not open market) | — |
Companies traded
- HROW Harrow, Inc: 1 buy, last Jun 18, 2026
- OCUL Ocular Therapeutix, Inc: other filings, last Jun 10, 2026
- IRD Opus Genetics, Inc: other filings, last Apr 20, 2026
- ISEE IVERIC bio, Inc: other filings, last Jul 11, 2023
- AKRX Akorn Inc: 1 sale, last May 9, 2019
- OPHT Ophthotech Corp: other filings, last Dec 12, 2018
- TEAR TearLab Corp: other filings, last Jun 24, 2016